7Karalis DG,Ross AM,Vacari RM,et al.Comparison of efficacy and safety of atorvastatin and simvastatin in patients with dyslipidemia with and without coronary heart disease.Am J Cardiol,2002,89:667-671.
二级参考文献29
1Cleeman JI. Executive summary of the third report of the mational cholesterol education program(NCEP)export panel on detection,evaluation,and treatment of high blood cholesterol in adults (adult treatment panel III).JAMA,2001,285:2486-2497.
2O'Driscoll G,Green D,Taylor RR. Simvastatin, an HMG-coenzyme a reductase inhibitor, improves endothelial function within 1 month. Circulation, 1997,95:1126-1131.
3Huggins GS, Pastemak RC, Alpert NM, et al. Effects of short-trem treatment of hyperlipidemia on coronary vasodilator function and myocardial perfusion in regions having substantial impairment of baseline dilator reserve.Circulation.1998,98:1291-1296.
4Dupuis J, Tardif JC, Cemacek P, et al. Cholesterol reduction rapidly improves endothelial function after acute conroary syndromes:the RECIFE (Reduction of cholesterol in Ischemia and Function of endothelium ) Trial. Circulation,1999,99:3227-3333.
5Bustos C, Hemandez-Presa MA,Ortego M,et al. HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis.J Am Coll Cardiol, 1998,32:2057-2064.
6Ridker PM, Rifai N, Pfeffer MA, et al. For the cholesterol and recurrent events(CARE) investigators. Long-term effects of pravastatin on plasma concentration of C-reactive protein. Circulation. 1999,100:230-235.
7Lacoste L, Lam JYT, Hung J, et al. Hyperlipidemia and coronary disease: correction of the increased thromhogenic potential with cholesterol reduction.Circulation, 1995,92: 3172-3177.
8Notarbartolo A, Davi G, Avema M, et al. Inhibition of thromboxane biosynthesis and platelet function by simvastain in type II a hypercholesterolemia.Arterisocler Thromb Vasc Biol, 1995,15:247-251.
9American Diabetes Association. Management of dyslipidemia in adults with diabetes( Position Statement). Diabetes Care, 1999,22(Suppl 1 ) : S56-S59.
10Stenestrand U, Walleatin L. Early statin treatment following acute myocardial infarction and 1-year survival.JAMA,2001.430-436.
1Angeja BG, de Lemos J, Murphy SA, et al. Impact of diabetes mellitus on epicardial and microvascular flow after fibrinolytic eherapy. Am Heart T, 2002,144:649-645.
